Detailseite
Projekt Druckansicht

Das Kälteschockprotein YB-1 bei chronischen T-Zellantworten und Systemischen Lupus Erythematodes (SLE)

Fachliche Zuordnung Rheumatologie
Förderung Förderung von 2016 bis 2020
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 292779965
 
Erstellungsjahr 2020

Zusammenfassung der Projektergebnisse

Understanding how deregulated apoptosis - not only of SLE T-cells - can be manipulated is a fundamental question in immunology. Within the project we could demonstrate for the first time that SLE T-cells can hardly upregulate the cold shock protein YB-1. Expression was a prerequisite for survival and has directed us to generate a model that explains chronicity of the SLE pathology. We identified PUMA for induction of apoptosis in the absence of YB-1 and the kinase Akt to be responsible for YB-1 mediated resistance against activation induced cell death. The results demonstrate that reduced YB-1 accumulation is a novel signatory function of SLE T-cells. Our results stress also the point that SLE cells show viability when YB-1 is re-expressed and, thus, can be manipulated by impinging on YB-1 signal transduction.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung